Muscular Dystrophy, Duchenne - 12 Studies Found

Recruiting : Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2011-12-22
Active, not recruiting : Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2013-08-01
:
  • Drug: NPC-14

Active, not recruiting : Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2015-04-29
:
  • Drug: Edasalonexent 67 mg/kg/d
Completed : Pentoxifylline in Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2005-01-29
: Drug: Pentoxifylline Pentoxifylline dosing: 20mg/Kg/day in a 20 mg/mL solution. Maximum dose of 1200mg/d
Recruiting : Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2014-07-17
:
  • Other: Magnetic Resonance Imaging (MRI)

Terminated : A Study of Tadalafil for Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2013-05-24
:
  • Drug: Tadalafil Administered o
Recruiting : Rimeporide in Patients With Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2016-01-26
: Drug: Rimeporide Cohort 1:
Completed : Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2006-02-23
:
  • Drug: L-Glutamine L-Glutamine
Completed : Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2001-05-21
:
  • Drug: Creatine Monohydrate
  • Drug: Glutamine
Active, not recruiting : Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy
: Muscular Dystrophy, Duchenne
: 2014-10-30
: Drug: eteplirsen Eteplirsen 30 mg/kg will be administered as an IV infusion once a week for up to 144 we
Next >>>